Tony Tyree - MEDIFAST INC Chief Marketing Officer

MED Stock  USD 38.32  0.79  2.10%   

Executive

Mr. Tony Tyree is Chief Marketing Officer of the Company. Tyree is charged with leading the company marketing, scientific and clinical affairs, nutrition support, product development, and strategic planning and program management teams. He most recently served as Vice President of Global Snacks at The Hershey Company, where he formulated the vision, mission and strategic pillars to increase the company presence in the global health and wellness snack category. Tyree brings more than 20 years of experience in the consumer packaged goods industry and has held various leadership roles at Fonterra LTD, Kraft Foods, Nabisco, and the Kellogg Company, giving him extensive marketing and general management experience both domestically and abroad, including the AsiaPacific market. since 2018.
Tenure 6 years
Address 100 International Drive, Baltimore, MD, United States, 21202
Phone410 581 8042
Webhttps://medifastinc.com

MEDIFAST INC Management Efficiency

The company has Return on Asset of 0.2524 % which means that on every $100 spent on assets, it made $0.2524 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.5577 %, implying that it generated $0.5577 on every 100 dollars invested. MEDIFAST INC's management efficiency ratios could be used to measure how well MEDIFAST INC manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Capital Employed is expected to grow to 0.61. The current year's Return On Assets is expected to grow to 0.34. At present, MEDIFAST INC's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 15.4 M, whereas Net Tangible Assets are forecasted to decline to about 125 M.
The company has 22.01 M in debt with debt to equity (D/E) ratio of 0.43, which is OK given its current industry classification. MEDIFAST INC has a current ratio of 1.26, demonstrating that it may not be capable to disburse its financial commitments when the payables are due. Debt can assist MEDIFAST INC until it has trouble settling it off, either with new capital or with free cash flow. So, MEDIFAST INC's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MEDIFAST INC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MEDIFAST to invest in growth at high rates of return. When we think about MEDIFAST INC's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Michael GillettMedirom Healthcare Technologies
N/A
Ryan SandsHR Block
N/A
Colby BrownHR Block
50
Akira AokiMedirom Healthcare Technologies
N/A
Thomas LuczynskiRollins
67
Evan IversonFrontdoor
N/A
David LofthouseMedirom Healthcare Technologies
N/A
Tiffany MonroeHR Block
51
Markus HartmannMister Car Wash
59
Thomas GerkeHR Block
64
Raj MidhaFrontdoor
N/A
Rachel EndrizziRegis Common
41
Jennifer JDRegis Common
N/A
Khazid OmarPrimech Holdings
59
Alan LowdenHR Block
N/A
Jackie LangRegis Common
N/A
Michael PomeroyRegis Common
57
Meredith DiagostinoFrontdoor
N/A
Michelle DeVoreRegis Common
N/A
Mark FoslandRegis Common
N/A
Daylan RobertsMedirom Healthcare Technologies
N/A
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company was founded in 1980 and is headquartered in Baltimore, Maryland. Medifast operates under Personal Services classification in the United States and is traded on New York Stock Exchange. It employs 984 people. MEDIFAST INC (MED) is traded on New York Stock Exchange in USA. It is located in 100 International Drive, Baltimore, MD, United States, 21202 and employs 634 people. MEDIFAST INC is listed under Personal Care Products category by Fama And French industry classification.

Management Performance

MEDIFAST INC Leadership Team

Elected by the shareholders, the MEDIFAST INC's board of directors comprises two types of representatives: MEDIFAST INC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MEDIFAST. The board's role is to monitor MEDIFAST INC's management team and ensure that shareholders' interests are well served. MEDIFAST INC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MEDIFAST INC's outside directors are responsible for providing unbiased perspectives on the board's policies.
Margaret Sheetz, President COO, Director
Ming Xian, Independent Director
Brian Kagen, Chief Marketing Officer and Executive VP
Anthony Tyree, Chief Marketing Officer
Michael Hoer, Independent Director
Timothy Robinson, Chief Financial Officer
Jeffrey Brown, Lead Independent Director
Fran Lawler, Chief Human Resource Officer
Lauren Walker, Executive Vice President - Supply Chain Operations
Glenn Welling, Independent Director
Jason Esq, General VP
Jason Groves, Executive Vice President, General Counsel, Corporate Secretary
Joseph Kelleman, Interim Chief Financial Officer, Vice President - Finance
Charles Connolly, Independent Director
James Maloney, Chief Financial Officer, Interim Principal Accounting Officer
Tony Tyree, Chief Marketing Officer
Donald Gould, Executive VP of Information Technology
Michael MacDonald, Chairman, CEO and Chairman of Executive Committee
Jeanne City, Executive Vice President - Human Resources
Jonathan Mackenzie, Chief Accounting Officer
Daniel Chard, Executive Chairman of the Board, Chief Executive Officer
James CPA, Chief Officer
Mehrnaz Ameli, President - Take Shape For Life
Bill Baker, Executive Vice President Information Technology
William Baker, Executive Vice President Information Technology
Stephen Johnson, Chief Accounting Officer, Vice President - Finance
Andrea Thomas, Independent Director
Steven Zenker, Vice Relations
Scott Schlackman, Independent Director
Kevin Byrnes, Independent Director
Carl Sassano, Independent Director
Constance Hallquist, Independent Director
Nicholas Johnson, Executive Vice President - Coach Success, Market President of OPTAVIA USA
Claudia Greninger, Executive Vice President - Human Resources

MEDIFAST Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MEDIFAST INC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.
Note that the MEDIFAST INC information on this page should be used as a complementary analysis to other MEDIFAST INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for MEDIFAST Stock analysis

When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Is MEDIFAST INC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Dividend Share
4.95
Earnings Share
9.1
Revenue Per Share
98.498
Quarterly Revenue Growth
(0.43)
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.